Scientific Sessions 2025  /  Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH  /  Combined Pre- and Post-Capillary PH: What Models Do We Use to Study the Disease?
Logo

American Heart Association

  71
  0

Final ID:

Combined Pre- and Post-Capillary PH: What Models Do We Use to Study the Disease?

  • Agrawal, Vineet  ( Vanderbilt University Medical Cente , Brentwood , Tennessee , United States )
  • Brittain, Evan  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • Maron, Brad  ( University of Maryland , Sharon , Massachusetts , United States )
    • Author Disclosures:
    Vineet Agrawal: DO NOT have relevant financial relationships | Evan Brittain: DO NOT have relevant financial relationships | Brad Maron: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations and Challenges in Preclinical Studies of Group 2 and Group 3 PH

Monday, 11/10/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Molecular Determinants of Vascular Remodeling in Group 3 PH

Karmouty-quintana Harry, Eghbali Mansoureh, Ruffenach Gregoire

Finding Drugs to Repurpose for Groups 2 and 3 PH: Is There Hope?

Spiekerkoetter Edda, Toshner Mark, Prins Kurt

More abstracts from these authors:
Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the Right Ventricle, and Treatment Targets

Maron Brad, Tedford Ryan, Brittain Evan

Myocardial Transcriptomics Differentiates Decompensated, Compensated, and Healthy Right Ventricular Samples in End Stage Heart Failure

Garry Jonah, Davogustto Giovanni, Agrawal Vineet, Brittain Evan

You have to be authorized to contact abstract author. Please, Login
Not Available